Add-on Combination Therapy with Metformin HCl plus an SGLT2 Inhibitor A total of 315 patients with type 2 diabetes mellitus participated in this 24-week randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of saxagliptin added to dapagliflozin (an SGLT2 inhibitor) and metformin HCl in patients with a baseline of HbA1c 7% to 10.5%
Does it speak to them, beyond being the source of their Friday night glass of wine, or beer, or cocktail ingredient
Trkeimpn havaintonaan tutkijat pitvt sit, ett valinta niden kahden lkeryhmn vlill tulisi tehd yksilllisesti potilaan muut sairaudet huomioon ottaen
Prior authorizations, high cash prices, and a system that keeps pushing obesity patients aside
FT282-CCNE1+PARGi, n = 101
Despite mixed messages about different protein sources, many GLP-1 users are prioritizing protein-rich foods as part of their weight loss and health maintenance efforts